Seigo Kakiuchi

Statistics

Publications

Citations

H-Index

Active since

2017

Affiliations

Jikei University School of Medicine(Current)

Kowa (Japan)

Sanofi (Japan)

Kawasaki Medical School

Seigo Kakiuchi is an author at Jikei University School of Medicine specializing in sodium-glucose cotransporter 2 inhibition, diabetes management, and diabetes mellitus.

ORCID

Publications per year

2017–2020

Publications

Safety and effectiveness of tofogliflozin in elderly Japanese patients with type 2 diabetes mellitus: A post‐marketing study (J‐<scp>STEP</scp>/<scp>EL</scp> Study)

Kazunori Utsunomiya, Naoki Shimmoto, Masayuki Senda et al. · Journal of Diabetes Investigation · 2017 · 30 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Safety and efficacy of tofogliflozin in Japanese patients with type 2 diabetes mellitus in real‐world clinical practice: Results of 3‐month interim analysis of a long‐term post‐marketing surveillance study (J‐STEP/LT)

Kazunori Utsunomiya, Masayuki Senda, Seigo Kakiuchi et al. · Journal of Diabetes Investigation · 2019 · 14 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Safety and effectiveness of tofogliflozin in Japanese patients with type 2 diabetes mellitus treated in real‐world clinical practice: Results of a 36‐month post‐marketing surveillance study (J‐STEP/LT)

Kazunori Utsunomiya, Ryusuke Koshida, Seigo Kakiuchi et al. · Journal of Diabetes Investigation · 2020 · 13 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Safety and effectiveness of tofogliflozin in Japanese patients with type 2 diabetes mellitus: Results of 24‐month interim analysis of a long‐term post‐marketing study (J‐STEP/LT)

Kazunori Utsunomiya, Seigo Kakiuchi, Masayuki Senda et al. · Journal of Diabetes Investigation · 2020 · 10 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

1–4 of 4